← Eichor
Condition: Endometrial Carcinoma Ec Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Endometrial Carcinoma Ec

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Phase N/A · 1 location(s) · National Cancer Institute, Naples · NCT06893861A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06925724Study of GV20-0251 in Participants With Solid Tumor Malignancies
Phase 1/Phase 2 · 3 location(s) · GV20 Therapeutics · NCT07070518Intrauterine Injection of Type III Collage in FST of EC/AEH
Phase 2 · 1 location(s) · Wang Jianliu · NCT07377734Endometrial Cancer Vaginal Fluid Specimen Collection Study
Phase N/A · 1 location(s) · Exact Sciences Corporation · NCT07544680A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recur
Phase 2 · 1 location(s) · GlaxoSmithKline · NCT07108270Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
Phase 2/Phase 3 · 1 location(s) · West China Second University Hospital · NCT03463252A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malign
Phase 1/Phase 2 · 13 location(s) · GV20 Therapeutics · NCT05669430TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
Phase 2 · 1 location(s) · Fudan University · NCT06914297
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.